Learn More
CBL (phospho Y700), Rabbit anti-Human, Polyclonal Antibody, Abnova™
Rabbit polyclonal antibody raised against synthetic phosphopeptide of CBL.
Supplier: Abnova Corporation PAB25918
Description
The cbl oncogene was first identified as part of a transforming retrovirus which induces mouse pre-B and pro-B cell lymphomas. As an adaptor protein for receptor protein-tyrosine kinases, it positively regulates receptor protein-tyrosine kinase ubiquitination in a manner dependent upon its variant SH2 and RING finger domains. Ubiquitination of receptor protein-tyrosine kinases terminates signaling by marking active receptors for degradation. [provided by RefSeq
Sequence: T-E-Yp-M-TSpecifications
CBL | |
Polyclonal | |
Unconjugated | |
Immunohistochemistry (1:50-1:100) Immunofluorescence (1:100-1:200) The optimal working dilution should be determined by the end user. | |
CBL | |
C-CBL/CBL2/RNF55 | |
Rabbit | |
Affinity chromatography | |
RUO | |
867 | |
Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Immunofluorescence, Immunohistochemistry (PFA fixed) | |
1 mg/mL | |
Rabbit polyclonal antibody raised against synthetic phosphopeptide of CBL. | |
In PBS (without mg2+ and Ca2+), 150mM NaCl, pH 7.4 (50% glycerol, 0.02% sodium azide) | |
P22681 | |
CBL | |
Synthetic phosphopeptide corresponding to residues surrounding Y700 of human CBL. | |
100 μg | |
Primary | |
Human | |
Liquid |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
For Research Use Only